News

ABOS
Acumen Pharmaceuticals, Inc. News

This news view pulls recent coverage and headlines tied to ABOS.

Latest Close

$0.19

1y Change

-$1.38 (-88.09%)

Market Cap

$13,489,045.00

Sector

Healthcare

Industry

Biotechnology

Recommendation

none

Alzheimer's families just lost one of their biggest hopes

TheStreet • Nov 10, 2026

Read article

Acumen Pharmaceuticals: 3 Key Takeaways for Long-Term Investors

Motley Fool • Nov 5, 2026

Read article

Cantor Fitzgerald Downgrades Acumen Pharmaceuticals to Underweight From Overweight

MT Newswires • Oct 30, 2026

Read article

Citigroup Downgrades Acumen Pharmaceuticals to Neutral From Buy, Price Target is $1

MT Newswires • Oct 30, 2026

Read article

BC-Most Active Stocks

Associated Press • Oct 30, 2026

Read article

Acumen Pharmaceuticals to Stop Sabirnetug Development in Alzheimer's After Phase 2 Trial Failure

MT Newswires • Oct 30, 2026

Read article